ChainCatcher news, the decentralized longevity science research organization VitaDAO announced the completion of a $4.1 million token financing, with participation from Pfizer's venture capital arm, Shine Capital, L1 Digital, and Balaji Srinivasan. This round of financing concluded this month, marking Pfizer's first investment in the web3 space. In September 2022, Pfizer announced a commitment of $500,000 to VitaDAO.It is reported that VitaDAO is part of a nascent movement known as decentralized science (DeSci). DeSci aims to replace the current scientific ecosystem that relies on centralized research and funding institutions by crowdfunding and decentralizing ownership to raise funds for research. The projects funded by VitaDAO primarily focus on longevity and the aging process, currently supporting Turn Biotechnologies, a Stanford University spin-off producing mRNA drugs, as well as a study at the University of Copenhagen on understanding the effects of drugs on the aging process. (The Block)